A R Mathers1,2, C D Carey1, M E Killeen1, J A Diaz-Perez1, S R Salvatore3, F J Schopfer3, B A Freeman3, L D Falo1,4. 1. Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 2. Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 3. Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 4. Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Abstract
BACKGROUND: Reactions between nitric oxide (NO), nitrite (NO2-), and unsaturated fatty acids give rise to electrophilic nitro-fatty acids (NO2 -FAs), such as nitro oleic acid (OA-NO2 ) and nitro linoleic acid (LNO2 ). Endogenous electrophilic fatty acids (EFAs) mediate anti-inflammatory responses by modulating metabolic and inflammatory signal transduction reactions. Hence, there is considerable interest in employing NO2 -FAs and other EFAs for the prevention and treatment of inflammatory disorders. Thus, we sought to determine whether OA-NO2 , an exemplary nitro-fatty acid, has the capacity to inhibit cutaneous inflammation. METHODS: We evaluated the effect of OA-NO2 on allergic contact dermatitis (ACD) using an established model of contact hypersensitivity in C57Bl/6 mice utilizing 2,4-dinitrofluorobenzene as the hapten. RESULTS: We found that subcutaneous (SC) OA-NO2 injections administered 18 h prior to sensitization and elicitation suppresses ACD in both preventative and therapeutic models. In vivo SC OA-NO2 significantly inhibits pathways that lead to inflammatory cell infiltration and the production of inflammatory cytokines in the skin. Moreover, OA-NO2 is capable of enhancing regulatory T-cell activity. Thus, OA-NO2 treatment results in anti-inflammatory effects capable of inhibiting ACD by inducing immunosuppressive responses. CONCLUSION: Overall, these results support the development of OA-NO2 as a promising therapeutic for ACD and provides new insights into the role of electrophilic fatty acids in the control of cutaneous immune responses potentially relevant to a broad range of allergic and inflammatory skin diseases.
BACKGROUND: Reactions between nitric oxide (NO), nitrite (NO2-), and unsaturated fatty acids give rise to electrophilicnitro-fatty acids (NO2 -FAs), such as nitro oleic acid (OA-NO2 ) and nitro linoleic acid (LNO2 ). Endogenous electrophilicfatty acids (EFAs) mediate anti-inflammatory responses by modulating metabolic and inflammatory signal transduction reactions. Hence, there is considerable interest in employing NO2 -FAs and other EFAs for the prevention and treatment of inflammatory disorders. Thus, we sought to determine whether OA-NO2 , an exemplary nitro-fatty acid, has the capacity to inhibit cutaneous inflammation. METHODS: We evaluated the effect of OA-NO2 on allergic contact dermatitis (ACD) using an established model of contact hypersensitivity in C57Bl/6 mice utilizing 2,4-dinitrofluorobenzene as the hapten. RESULTS: We found that subcutaneous (SC) OA-NO2 injections administered 18 h prior to sensitization and elicitation suppresses ACD in both preventative and therapeutic models. In vivo SC OA-NO2 significantly inhibits pathways that lead to inflammatory cell infiltration and the production of inflammatory cytokines in the skin. Moreover, OA-NO2 is capable of enhancing regulatory T-cell activity. Thus, OA-NO2 treatment results in anti-inflammatory effects capable of inhibiting ACD by inducing immunosuppressive responses. CONCLUSION: Overall, these results support the development of OA-NO2 as a promising therapeutic for ACD and provides new insights into the role of electrophilicfatty acids in the control of cutaneous immune responses potentially relevant to a broad range of allergic and inflammatory skin diseases.
Authors: Bruce A Freeman; Paul R S Baker; Francisco J Schopfer; Steven R Woodcock; Alessandra Napolitano; Marco d'Ischia Journal: J Biol Chem Date: 2008-02-19 Impact factor: 5.157
Authors: Hideaki Watanabe; Adam J Mamelak; Binghe Wang; Brandon G Howell; Irwin Freed; Clemens Esche; Masashi Nakayama; Go Nagasaki; Daniel J Hicklin; Robert S Kerbel; Daniel N Sauder Journal: Exp Dermatol Date: 2004-11 Impact factor: 3.960
Authors: Paul R S Baker; Yiming Lin; Francisco J Schopfer; Steven R Woodcock; Alison L Groeger; Carlos Batthyany; Scott Sweeney; Marshall H Long; Karen E Iles; Laura M S Baker; Bruce P Branchaud; Yuqing E Chen; Bruce A Freeman Journal: J Biol Chem Date: 2005-10-14 Impact factor: 5.157
Authors: Emilia Kansanen; Henna-Kaisa Jyrkkänen; Oscar L Volger; Hanna Leinonen; Annukka M Kivelä; Sanna-Kaisa Häkkinen; Steven R Woodcock; Francisco J Schopfer; Anton J Horrevoets; Seppo Ylä-Herttuala; Bruce A Freeman; Anna-Liisa Levonen Journal: J Biol Chem Date: 2009-10-05 Impact factor: 5.157
Authors: M Teresa Cruz; Carlos B Duarte; Margarida Gonçalo; Américo Figueiredo; Arsélio P Carvalho; M Celeste Lopes Journal: Arch Dermatol Res Date: 2002-10-29 Impact factor: 3.017
Authors: Alicia R Mathers; Cara D Carey; Meaghan E Killeen; Sonia R Salvatore; Laura K Ferris; Bruce A Freeman; Francisco J Schopfer; Louis D Falo Journal: Free Radic Biol Med Date: 2017-11-10 Impact factor: 7.376
Authors: Marco Fazzari; Dario A Vitturi; Steven R Woodcock; Sonia R Salvatore; Bruce A Freeman; Francisco J Schopfer Journal: J Lipid Res Date: 2018-12-13 Impact factor: 5.922
Authors: Sonia R Salvatore; Dario A Vitturi; Marco Fazzari; Diane K Jorkasky; Francisco J Schopfer Journal: Sci Rep Date: 2017-01-05 Impact factor: 4.379